Ribonucleotide Reductase Subunit M2 Can Be New Molecular Target and Prognostic Biomarker of Hepatocellular Carcinoma.

Author: Hee Yeon KIM ¹ ; Chang Wook KIM
Author Information

1. Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea. cwkim@catholic.ac.kr
Publication Type:Editorial ; Comment
MeSH: Carcinoma, Hepatocellular/*metabolism; Female; Humans; Liver Neoplasms/*metabolism; Male; Neoplasm Recurrence, Local/*metabolism; Ribonucleoside Diphosphate Reductase/*metabolism; Tumor Markers, Biological/*metabolism
From:Gut and Liver 2014;8(6):580-581
CountryRepublic of Korea
Language:English
Abstract: No abstract available.